news New potential targeted therapy strategy for triple negative breast cancer 30 January 2020 | By Victoria Rees (Drug Target Review) A study has shown that targeting the proteins mtp53 and PARP in triple negative breast cancer could inhibit tumour growth and provide a new treatment option.
news Researchers image C. diff toxins to aid in drug design 3 January 2020 | By Victoria Rees (Drug Target Review) A new study has used several imaging techniques to characterise C. diff toxins, which could help to design drugs to combat infections from the bacteria.